SCHEMBL18049064

SCHEMBL18049064

COC(=N)C1=CCCN(C)C1

nearest known ligand 0.64

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 2/20 0.64
CHRM4 P08173 2/20 0.64
CHRM5 P08912 2/20 0.64
CHRM1 P11229 2/20 0.64
CHRM3 P20309 2/20 0.64
LMNA P02545 1/20 0.64
THRB P10828 1/20 0.64
BLM P54132 1/20 0.62
MCOLN3 Q8TDD5 1/20 0.62
CHRNB2 P17787 1/20 0.50
CHRNA4 P43681 1/20 0.50
CYP1A2 P05177 1/20 0.45
CYP2D6 P10635 1/20 0.45
NFKB1 P19838 1/20 0.45
THPO P40225 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Arecoline SCHEMBL44065 0.78 CHRM2 (1.00) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL640797 0.78 CHRM2 (0.54) CHRM2CHRM4CHRM5CHRM1CHRM3
Arecoline SCHEMBL527735 0.76 BLM (1.00) CHRM2CHRM4CHRM5CHRM1CHRM3
Arecoline SCHEMBL3057863 0.76 CHRM2 (0.96) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL9581487 0.76 CHRM3 (0.45) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL9594622 0.71 CHRM2 (0.56) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL12043327 0.71 CHRM2 (0.56) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL5203140 0.71 CHRM2 (0.65) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL336164 0.71 CHRM2 (0.65) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL9568926 0.71 CHRM2 (0.65) CHRM2CHRM4CHRM5CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3265466-A1 PERIPHERAL-ANTICHOLINERGIC MUSCARINIC AGONIST COMBINATION Chase Pharmaceuticals Corporation (US) 2018-01-10 EP claimed
WO-2016144727-A1 PERIPHERAL-ANTICHOLINERGIC MUSCARINIC AGONIST COMBINATION CHASE PHARMACEUTICALS CORPORATION (US) 2016-09-15 WO claimed